{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T14:48:40Z","timestamp":1782139720478,"version":"3.54.5"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"vor","delay-in-days":31,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Youth Project of Shanxi Province Health Commission","award":["2024036"],"award-info":[{"award-number":["2024036"]}]},{"name":"Guiding Science and Technology Special Projects of Shanxi Province Health Commission","award":["2025YD015"],"award-info":[{"award-number":["2025YD015"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08316-6","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T16:30:41Z","timestamp":1779467441000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["IGF2BP2-driven serine metabolism promotes the progression of thyroid carcinoma via m6A-PHGDH"],"prefix":"10.1186","volume":"24","author":[{"given":"Yuhang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhifu","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuqin","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6927-5377","authenticated-orcid":false,"given":"Qiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,22]]},"reference":[{"issue":"5","key":"8316_CR1","first-page":"425","volume":"331","author":"L Boucai","year":"2024","unstructured":"Boucai L, Zafereo M, Cabanillas ME. Thyroid Cancer: Rev Jama. 2024;331(5):425\u201335.","journal-title":"Thyroid Cancer: Rev Jama"},{"key":"8316_CR2","doi-asserted-by":"publisher","first-page":"122110","DOI":"10.1016\/j.lfs.2023.122110","volume":"332","author":"S Bhattacharya","year":"2023","unstructured":"Bhattacharya S, Mahato RK, Singh S, Bhatti GK, Mastana SS, Bhatti JS. Advances and challenges in thyroid cancer: The interplay of genetic modulators, targeted therapies, and AI-driven approaches. Life Sci. 2023;332:122110.","journal-title":"Life Sci"},{"issue":"6","key":"8316_CR3","doi-asserted-by":"publisher","first-page":"443","DOI":"10.3322\/caac.21637","volume":"70","author":"KD Miller","year":"2020","unstructured":"Miller KD, Fidler-Benaoudia M, Keegan TH, Hipp HS, Jemal A, Siegel RL. Cancer statistics for adolescents and young adults, 2020. Cancer J Clin. 2020;70(6):443\u201359.","journal-title":"Cancer J Clin"},{"issue":"2","key":"8316_CR4","doi-asserted-by":"publisher","first-page":"73","DOI":"10.5125\/jkaoms.2025.51.2.73","volume":"51","author":"Y Shin","year":"2025","unstructured":"Shin Y, Kim H, Yang S, Han SY, Cho ES, Kim D, et al. Mandibular metastasis of papillary thyroid carcinoma: a case report and systematic literature review. J Korean Association Oral Maxillofacial Surg. 2025;51(2):73\u20139.","journal-title":"J Korean Association Oral Maxillofacial Surg"},{"issue":"2","key":"8316_CR5","doi-asserted-by":"publisher","first-page":"393","DOI":"10.3892\/ol.2025.15139","volume":"30","author":"L Xu","year":"2025","unstructured":"Xu L, Zhang W, Wang Y, Le Q, Xie Y, Yu K, et al. Advances in lenvatinib monotherapy and combination therapies in anaplastic thyroid cancer (Review). Oncol Lett. 2025;30(2):393.","journal-title":"Oncol Lett"},{"issue":"1","key":"8316_CR6","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13044-022-00130-8","volume":"15","author":"B Cosway","year":"2022","unstructured":"Cosway B, Fussey J, Kim D, Wykes J, Elliott M, Smith J. Sporadic medullary thyroid cancer: a systematic review and meta-analysis of clinico-pathological and mutational characteristics predicting recurrence. Thyroid Res. 2022;15(1):12.","journal-title":"Thyroid Res"},{"key":"8316_CR7","doi-asserted-by":"crossref","unstructured":"Forma A, K\u0142odnicka K, Paj\u0105k W, Flieger J, Teresi\u0144ska B, Januszewski J, et al. Thyroid cancer: epidemiology, classification, risk factors, diagnostic and prognostic markers, and current treatment strategies. Int J Mol Sci. 2025;26(11).","DOI":"10.3390\/ijms26115173"},{"issue":"3","key":"8316_CR8","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s12020-023-03507-3","volume":"82","author":"S Yang","year":"2023","unstructured":"Yang S, Zhan J, Xu X. Evaluation of progression-free survival as a surrogate endpoint for overall survival in locally advanced or metastatic differentiated thyroid cancer: a systematic review. Endocrine. 2023;82(3):491\u20137.","journal-title":"Endocrine"},{"issue":"1","key":"8316_CR9","doi-asserted-by":"publisher","first-page":"100032","DOI":"10.1016\/j.gmg.2024.100032","volume":"12","author":"AT Aborode","year":"2025","unstructured":"Aborode AT, Abass OA, Nasiru S, Eigbobo MU, Nefishatu S, Idowu A, et al. RNA binding proteins (RBPs) on genetic stability and diseases. Global Med Genet. 2025;12(1):100032.","journal-title":"Global Med Genet"},{"key":"8316_CR10","doi-asserted-by":"crossref","unstructured":"Preckwinkel P, Mir KUI, Otto FW, Elrewany H, Sinz A, H\u00fcttelmaier S, et al. Long non-coding RNAs and RNA-binding proteins in pancreatic cancer development and progression. Cancers. 2025;17(10).","DOI":"10.3390\/cancers17101601"},{"issue":"1","key":"8316_CR11","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s40364-023-00499-0","volume":"11","author":"TY Zhu","year":"2023","unstructured":"Zhu TY, Hong LL, Ling ZQ. Oncofetal protein IGF2BPs in human cancer: functions, mechanisms and therapeutic potential. Biomark Res. 2023;11(1):62.","journal-title":"Biomark Res"},{"issue":"2","key":"8316_CR12","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1128\/MCB.19.2.1262","volume":"19","author":"J Nielsen","year":"1999","unstructured":"Nielsen J, Christiansen J, Lykke-Andersen J, Johnsen AH, Wewer UM, Nielsen FC. A family of insulin-like growth factor II mRNA-binding proteins represses translation in late development. Mol Cell Biol. 1999;19(2):1262\u201370.","journal-title":"Mol Cell Biol"},{"issue":"1","key":"8316_CR13","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s13046-024-02996-y","volume":"43","author":"H Cai","year":"2024","unstructured":"Cai H, Liang J, Jiang Y, Wang Z, Li H, Wang W, et al. KLF7 regulates super-enhancer-driven IGF2BP2 overexpression to promote the progression of head and neck squamous cell carcinoma. J experimental Clin cancer research: CR. 2024;43(1):69.","journal-title":"J experimental Clin cancer research: CR"},{"key":"8316_CR14","doi-asserted-by":"crossref","unstructured":"Hu Y, Chen J, Liu M, Feng Q, Peng H. IGF2BP2 serves as a core m6A regulator in head and neck squamous cell carcinoma. Biosci Rep. 2022;42(11).","DOI":"10.1042\/BSR20221311"},{"issue":"1","key":"8316_CR15","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/s41420-023-01707-4","volume":"9","author":"J Wang","year":"2023","unstructured":"Wang J, Zhu M, Zhu J, Li J, Zhu X, Wang K, et al. HES1 promotes aerobic glycolysis and cancer progression of colorectal cancer via IGF2BP2-mediated GLUT1 m6A modification. Cell death discovery. 2023;9(1):411.","journal-title":"Cell death discovery"},{"issue":"9","key":"8316_CR16","doi-asserted-by":"publisher","first-page":"e1389","DOI":"10.1002\/ctm2.1389","volume":"13","author":"H Zhang","year":"2023","unstructured":"Zhang H, Wu D, Wang Y, Guo K, Spencer CB, Ortoga L, et al. METTL3-mediated N6-methyladenosine exacerbates ferroptosis via m6A-IGF2BP2-dependent mitochondrial metabolic reprogramming in sepsis-induced acute lung injury. Clin translational Med. 2023;13(9):e1389.","journal-title":"Clin translational Med"},{"issue":"12","key":"8316_CR17","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1016\/j.ccell.2022.10.004","volume":"40","author":"H Weng","year":"2022","unstructured":"Weng H, Huang F, Yu Z, Chen Z, Prince E, Kang Y, et al. The m(6)A reader IGF2BP2 regulates glutamine metabolism and represents a therapeutic target in acute myeloid leukemia. Cancer Cell. 2022;40(12):1566\u2013e8210.","journal-title":"Cancer Cell"},{"issue":"3","key":"8316_CR18","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/s41556-018-0045-z","volume":"20","author":"H Huang","year":"2018","unstructured":"Huang H, Weng H, Sun W, Qin X, Shi H, Wu H, et al. Recognition of RNA N(6)-methyladenosine by IGF2BP proteins enhances mRNA stability and translation. Nat Cell Biol. 2018;20(3):285\u201395.","journal-title":"Nat Cell Biol"},{"issue":"1","key":"8316_CR19","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1038\/s41467-023-36708-5","volume":"14","author":"K Wang","year":"2023","unstructured":"Wang K, Luo L, Fu S, Wang M, Wang Z, Dong L, et al. PHGDH arginine methylation by PRMT1 promotes serine synthesis and represents a therapeutic vulnerability in hepatocellular carcinoma. Nat Commun. 2023;14(1):1011.","journal-title":"Nat Commun"},{"issue":"7911","key":"8316_CR20","first-page":"747","volume":"605","author":"M Rossi","year":"2022","unstructured":"Rossi M, Altea-Manzano P, Demicco M, Doglioni G, Bornes L, Fukano M, et al. PHGDH heterogeneity potentiates cancer cell dissemination metastasis Nat. 2022;605(7911):747\u201353.","journal-title":"PHGDH heterogeneity potentiates cancer cell dissemination metastasis Nat"},{"issue":"7","key":"8316_CR21","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1038\/s12276-024-01268-1","volume":"56","author":"CM Lee","year":"2024","unstructured":"Lee CM, Hwang Y, Kim M, Park YC, Kim H, Fang S. PHGDH: a novel therapeutic target in cancer. Exp Mol Med. 2024;56(7):1513\u201322.","journal-title":"Exp Mol Med"},{"key":"8316_CR22","doi-asserted-by":"publisher","first-page":"104352","DOI":"10.1016\/j.phrs.2019.104352","volume":"149","author":"JD Zeng","year":"2019","unstructured":"Zeng JD, Wu WKK, Wang HY, Li XX. Serine and one-carbon metabolism, a bridge that links mTOR signaling and DNA methylation in cancer. Pharmacol Res. 2019;149:104352.","journal-title":"Pharmacol Res"},{"issue":"6","key":"8316_CR23","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1016\/j.cmet.2019.02.015","volume":"29","author":"MR Sullivan","year":"2019","unstructured":"Sullivan MR, Mattaini KR, Dennstedt EA, Nguyen AA, Sivanand S, Reilly MF, et al. Increased Serine Synthesis Provides an Advantage for Tumors Arising in Tissues Where Serine Levels Are Limiting. Cell Metabol. 2019;29(6):1410\u2013e214.","journal-title":"Cell Metabol"},{"issue":"1","key":"8316_CR24","doi-asserted-by":"publisher","first-page":"4790","DOI":"10.1038\/s41467-024-49087-2","volume":"15","author":"L Luo","year":"2024","unstructured":"Luo L, Wu X, Fan J, Dong L, Wang M, Zeng Y, et al. FBXO7 ubiquitinates PRMT1 to suppress serine synthesis and tumor growth in hepatocellular carcinoma. Nat Commun. 2024;15(1):4790.","journal-title":"Nat Commun"},{"issue":"5","key":"8316_CR25","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/s41423-024-01134-0","volume":"21","author":"Z Cai","year":"2024","unstructured":"Cai Z, Li W, Hager S, Wilson JL, Afjehi-Sadat L, Heiss EH, et al. Targeting PHGDH reverses the immunosuppressive phenotype of tumor-associated macrophages through \u03b1-ketoglutarate and mTORC1 signaling. Cell Mol Immunol. 2024;21(5):448\u201365.","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"8316_CR26","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s13046-025-03361-3","volume":"44","author":"X Liu","year":"2025","unstructured":"Liu X, Liu B, Wang J, Liu H, Wu J, Qi Y, et al. PHGDH activation fuels glioblastoma progression and radioresistance via serine synthesis pathway. J experimental Clin cancer research: CR. 2025;44(1):99.","journal-title":"J experimental Clin cancer research: CR"},{"key":"8316_CR27","doi-asserted-by":"crossref","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17\u201348.","DOI":"10.3322\/caac.21763"},{"issue":"11","key":"8316_CR28","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1056\/NEJMra1501993","volume":"375","author":"JA Fagin","year":"2016","unstructured":"Fagin JA, Wells SA. Jr. Biologic and Clinical Perspectives on Thyroid Cancer. N Engl J Med. 2016;375(11):1054\u201367.","journal-title":"N Engl J Med"},{"issue":"3","key":"8316_CR29","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.cmet.2022.01.007","volume":"34","author":"NN Pavlova","year":"2022","unstructured":"Pavlova NN, Zhu J, Thompson CB. The hallmarks of cancer metabolism: Still emerging. Cell Metabol. 2022;34(3):355\u201377.","journal-title":"Cell Metabol"},{"issue":"3","key":"8316_CR30","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.cmet.2023.01.010","volume":"35","author":"D Zhang","year":"2023","unstructured":"Zhang D, Li AM, Hu G, Huang M, Yang F, Zhang L, et al. PHGDH-mediated endothelial metabolism drives glioblastoma resistance to chimeric antigen receptor T cell immunotherapy. Cell Metabol. 2023;35(3):517\u2013e348.","journal-title":"Cell Metabol"},{"key":"8316_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.omtn.2020.09.023","volume":"23","author":"M Ye","year":"2021","unstructured":"Ye M, Dong S, Hou H, Zhang T, Shen M. Oncogenic Role of Long Noncoding RNAMALAT1 in Thyroid Cancer Progression through Regulation of the miR-204\/IGF2BP2\/m6A-MYC Signaling. Mol therapy Nucleic acids. 2021;23:1\u201312.","journal-title":"Mol therapy Nucleic acids"},{"key":"8316_CR32","doi-asserted-by":"publisher","first-page":"153550","DOI":"10.1016\/j.prp.2021.153550","volume":"225","author":"L Dong","year":"2021","unstructured":"Dong L, Geng Z, Liu Z, Tao M, Pan M, Lu X. IGF2BP2 knockdown suppresses thyroid cancer progression by reducing the expression of long non-coding RNA HAGLR. Pathol Res Pract. 2021;225:153550.","journal-title":"Pathol Res Pract"},{"issue":"1","key":"8316_CR33","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13046-022-02254-z","volume":"41","author":"J Huang","year":"2022","unstructured":"Huang J, Sun W, Wang Z, Lv C, Zhang T, Zhang D, et al. FTO suppresses glycolysis and growth of papillary thyroid cancer via decreasing stability of APOE mRNA in an N6-methyladenosine-dependent manner. J experimental Clin cancer research: CR. 2022;41(1):42.","journal-title":"J experimental Clin cancer research: CR"},{"issue":"10","key":"8316_CR34","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/s41419-024-07097-4","volume":"15","author":"Z Chen","year":"2024","unstructured":"Chen Z, Zhong X, Xia M, Liu C, Tang W, Liu G, et al. FTO\/IGF2BP2-mediated N6 methyladenosine modification in invasion and metastasis of thyroid carcinoma via CDH12. Cell Death Dis. 2024;15(10):733.","journal-title":"Cell Death Dis"},{"issue":"2","key":"8316_CR35","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/s41417-023-00702-2","volume":"31","author":"W Wang","year":"2024","unstructured":"Wang W, Ding Y, Zhao Y, Li X. m6A reader IGF2BP2 promotes lymphatic metastasis by stabilizing DPP4 in papillary thyroid carcinoma. Cancer Gene Ther. 2024;31(2):285\u201399.","journal-title":"Cancer Gene Ther"},{"key":"8316_CR36","doi-asserted-by":"publisher","first-page":"795386","DOI":"10.3389\/fphar.2021.795386","volume":"12","author":"R Sa","year":"2021","unstructured":"Sa R, Guo M, Liu D, Guan F. AhR Antagonist Promotes Differentiation of Papillary Thyroid Cancer via Regulating circSH2B3\/miR-4640-5P\/IGF2BP2 Axis. Front Pharmacol. 2021;12:795386.","journal-title":"Front Pharmacol"},{"key":"8316_CR37","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.canlet.2021.12.005","volume":"527","author":"R Sa","year":"2022","unstructured":"Sa R, Liang R, Qiu X, He Z, Liu Z, Chen L. IGF2BP2-dependent activation of ERBB2 signaling contributes to acquired resistance to tyrosine kinase inhibitor in differentiation therapy of radioiodine-refractory papillary thyroid cancer. Cancer Lett. 2022;527:10\u201323.","journal-title":"Cancer Lett"},{"issue":"5","key":"8316_CR38","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.devcel.2016.02.012","volume":"36","author":"AM Hosios","year":"2016","unstructured":"Hosios AM, Hecht VC, Danai LV, Johnson MO, Rathmell JC, Steinhauser ML, et al. Amino Acids Rather than Glucose Account for the Majority of Cell Mass in Proliferating Mammalian Cells. Dev Cell. 2016;36(5):540\u20139.","journal-title":"Dev Cell"},{"key":"8316_CR39","doi-asserted-by":"publisher","first-page":"113379","DOI":"10.1016\/j.ejmech.2021.113379","volume":"217","author":"JY Zhao","year":"2021","unstructured":"Zhao JY, Feng KR, Wang F, Zhang JW, Cheng JF, Lin GQ, et al. A retrospective overview of PHGDH and its inhibitors for regulating cancer metabolism. Eur J Med Chem. 2021;217:113379.","journal-title":"Eur J Med Chem"},{"issue":"9","key":"8316_CR40","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1038\/ng.890","volume":"43","author":"JW Locasale","year":"2011","unstructured":"Locasale JW, Grassian AR, Melman T, Lyssiotis CA, Mattaini KR, Bass AJ, et al. Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis. Nat Genet. 2011;43(9):869\u201374.","journal-title":"Nat Genet"},{"issue":"5","key":"8316_CR41","doi-asserted-by":"publisher","first-page":"4457","DOI":"10.1007\/s13277-013-1588-z","volume":"35","author":"S Noh","year":"2014","unstructured":"Noh S, Kim DH, Jung WH, Koo JS. Expression levels of serine\/glycine metabolism-related proteins in triple negative breast cancer tissues. Tumour biology: J Int Soc Oncodevelopmental Biology Med. 2014;35(5):4457\u201368.","journal-title":"Tumour biology: J Int Soc Oncodevelopmental Biology Med"},{"issue":"8","key":"8316_CR42","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/s41419-023-06041-2","volume":"14","author":"Y Hwang","year":"2023","unstructured":"Hwang Y, Yun HJ, Jeong JW, Kim M, Joo S, Lee HK, et al. Co-inhibition of glutaminolysis and one-carbon metabolism promotes ROS accumulation leading to enhancement of chemotherapeutic efficacy in anaplastic thyroid cancer. Cell Death Dis. 2023;14(8):515.","journal-title":"Cell Death Dis"},{"key":"8316_CR43","doi-asserted-by":"crossref","unstructured":"Zhang X, Sun M, Jiao Y, Lin B, Yang Q. PHGDH inhibitor CBR-5884 inhibits epithelial ovarian cancer progression via ROS\/Wnt\/\u03b2-catenin pathway and plays a synergistic role with PARP inhibitor olaparib. Oxidative medicine and cellular longevity. 2022;2022:9029544.","DOI":"10.1155\/2022\/9029544"},{"issue":"726","key":"8316_CR44","doi-asserted-by":"publisher","first-page":"eade4113","DOI":"10.1126\/scitranslmed.ade4113","volume":"15","author":"C Zhang","year":"2023","unstructured":"Zhang C, Yu JJ, Yang C, Yuan ZL, Zeng H, Wang JJ, et al. Wild-type IDH1 maintains NSCLC stemness and chemoresistance through activation of the serine biosynthetic pathway. Sci Transl Med. 2023;15(726):eade4113.","journal-title":"Sci Transl Med"},{"issue":"19","key":"8316_CR45","doi-asserted-by":"publisher","first-page":"3516","DOI":"10.1158\/0008-5472.CAN-21-4074","volume":"82","author":"MY Luo","year":"2022","unstructured":"Luo MY, Zhou Y, Gu WM, Wang C, Shen NX, Dong JK, et al. Metabolic and Nonmetabolic Functions of PSAT1 Coordinate Signaling Cascades to Confer EGFR Inhibitor Resistance and Drive Progression in Lung Adenocarcinoma. Cancer Res. 2022;82(19):3516\u201331.","journal-title":"Cancer Res"},{"issue":"1","key":"8316_CR46","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41392-020-0147-5","volume":"5","author":"H Wang","year":"2020","unstructured":"Wang H, Cui L, Li D, Fan M, Liu Z, Liu C, et al. Overexpression of PSAT1 regulated by G9A sustains cell proliferation in colorectal cancer. Signal Transduct Target therapy. 2020;5(1):47.","journal-title":"Signal Transduct Target therapy"},{"key":"8316_CR47","doi-asserted-by":"publisher","first-page":"5443","DOI":"10.2147\/OTT.S250066","volume":"13","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Li J, Dong X, Meng D, Zhi X, Yuan L, et al. PSAT1 Regulated Oxidation-Reduction Balance Affects the Growth and Prognosis of Epithelial Ovarian Cancer. OncoTargets therapy. 2020;13:5443\u201353.","journal-title":"OncoTargets therapy"},{"issue":"2","key":"8316_CR48","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1002\/cbin.11489","volume":"45","author":"J Zhang","year":"2021","unstructured":"Zhang J, Wang E, Zhang L, Zhou B. PSPH induces cell autophagy and promotes cell proliferation and invasion in the hepatocellular carcinoma cell line Huh7 via the AMPK\/mTOR\/ULK1 signaling pathway. Cell Biol Int. 2021;45(2):305\u201319.","journal-title":"Cell Biol Int"},{"issue":"13","key":"8316_CR49","doi-asserted-by":"publisher","first-page":"2448","DOI":"10.1038\/s41388-021-01683-y","volume":"40","author":"V Rawat","year":"2021","unstructured":"Rawat V, Malvi P, Della Manna D, Yang ES, Bugide S, Zhang X, et al. PSPH promotes melanoma growth and metastasis by metabolic deregulation-mediated transcriptional activation of NR4A1. Oncogene. 2021;40(13):2448\u201362.","journal-title":"Oncogene"},{"issue":"7650","key":"8316_CR50","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/nature22056","volume":"544","author":"ODK Maddocks","year":"2017","unstructured":"Maddocks ODK, Athineos D, Cheung EC, Lee P, Zhang T, van den Broek NJF, et al. Modulating the therapeutic response of tumours to dietary serine and glycine starvation. Nature. 2017;544(7650):372\u20136.","journal-title":"Nature"},{"issue":"7831","key":"8316_CR51","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1038\/s41586-020-2609-x","volume":"586","author":"T Muthusamy","year":"2020","unstructured":"Muthusamy T, Cordes T, Handzlik MK, You L, Lim EW, Gengatharan J, et al. Serine restriction alters sphingolipid diversity to constrain tumour growth. Nature. 2020;586(7831):790\u20135.","journal-title":"Nature"},{"issue":"12","key":"8316_CR52","doi-asserted-by":"publisher","first-page":"4435","DOI":"10.1016\/j.ymthe.2024.10.025","volume":"32","author":"FF Chan","year":"2024","unstructured":"Chan FF, Kwan KK, Seoung DH, Chin DW, Ng IO, Wong CC, et al. N6-Methyladenosine modification activates the serine synthesis pathway to mediate therapeutic resistance in liver cancer. Mol therapy: J Am Soc Gene Therapy. 2024;32(12):4435\u201347.","journal-title":"Mol therapy: J Am Soc Gene Therapy"},{"issue":"1","key":"8316_CR53","doi-asserted-by":"publisher","first-page":"4214","DOI":"10.1038\/s41467-025-58966-1","volume":"16","author":"F Huang","year":"2025","unstructured":"Huang F, Wang Y, Zhang X, Gao W, Li J, Yang Y, et al. m(6)A\/IGF2BP3-driven serine biosynthesis fuels AML stemness and metabolic vulnerability. Nat Commun. 2025;16(1):4214.","journal-title":"Nat Commun"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08316-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08316-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08316-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T14:06:18Z","timestamp":1782137178000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08316-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,22]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8316"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08316-6","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,22]]},"assertion":[{"value":"16 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All human samples were collected after written informed consent was obtained from the research participants. All experimental procedures involving human tissues were approved by the Medical Ethics Committee of Shanxi Provincial People\u2019s Hospital (approval no. 2023\u2009\u2212\u2009288; Taiyuan, China) and were conducted in accordance with the World Medical Association Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects. The samples were used to optimize antibody concentrations, antigen retrieval methods, and staining protocols before the final optimized conditions were applied to the commercial TMA. All animal experiments were performed in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals and were approved by the Medical Ethics Committee of Shanxi Provincial People\u2019s Hospital (approval no. 2024\u2013700; Taiyuan, China).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"796"}}